Drug Shortage Report for ASACOL 800
Report ID | 120327 |
Drug Identification Number | 02267217 |
Brand name | ASACOL 800 |
Common or Proper name | mesalamine |
Company Name | ALLERGAN INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | MESALAZINE |
Strength(s) | 800MG |
Dosage form(s) | TABLET (DELAYED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 180 tabs |
ATC code | A07EC |
ATC description | INTESTINALANTIINFLAMMATORY AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-01-27 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | 2021-01-13 |
Shortage status | Resolved |
Updated date | 2021-01-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2021-01-28 | French | Compare |
v8 | 2021-01-28 | English | Compare |
v7 | 2020-12-11 | French | Compare |
v6 | 2020-12-11 | English | Compare |
v5 | 2020-08-26 | French | Compare |
v4 | 2020-08-26 | English | Compare |
v3 | 2020-07-14 | French | Compare |
v2 | 2020-07-14 | English | Compare |
v1 | 2020-07-14 | English | Compare |
Showing 1 to 9 of 9